Selected outcome
Influenza
9%
Influenza · 9%
Stored quote · checking the venue
- Scheduled end
- Jan 1, 2027 ET
- Resolution source
- CDC (opens in a new tab)
Price
Loading price history.
Markets
- COVID-19
Will the CDC end its recommendation for the COVID-19 vaccine?
18%
Open · ~$0 24h · ~$878 vol
Bid 15¢ · Ask 21¢
- Dengue
Will the CDC end its recommendation for the Dengue vaccine?
4%
Open · ~$0 24h · ~$15 vol
Bid 1¢ · Ask 6¢
- Influenza
Will the CDC end its recommendation for the Influenza vaccine?
9%
Open · ~$0 24h · ~$114 vol
Bid 6.1¢ · Ask 11¢
- Hepatitis B
Will the CDC end its recommendation for the Hepatitis B vaccine?
6%
Open · ~$0 24h · ~$45 vol
Bid 3.6¢ · Ask 7.7¢
- Polio
Will the CDC end its recommendation for the Polio vaccine?
5%
Open · ~$0 24h · ~$8 vol
Bid 4¢ · Ask 5.2¢
- Rotavirus
Will the CDC end its recommendation for the Rotavirus vaccine?
4%
Open · ~$0 24h · ~$5 vol
Bid 2¢ · Ask 6.1¢
Event statistics
How this resolves
- Scheduled end
- Jan 1, 2027 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If the CDC ends its recommendation completely for the Influenza vaccine before Jan 1, 2027, then the market resolves to Yes.